SST3-selective potent peptidic somatostatin receptor antagonists. - Wikidata - wikimedia - TriplyDB

SST3-selective potent peptidic somatostatin receptor antagonists.

SST3-selective potent peptidic somatostatin receptor antagonists.

http://www.wikidata.org/entity/Q35582980

about

Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives.Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets.Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms.Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.The biology and physiology of somatostatin receptors.Somatostatin, a negative-regulator of central leptin action in the rat hypothalamus.Different somatostatin receptor subtypes are operating in the brain of the teleost fish, Coris julis.Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature Molecular Modeling Suggests Conformational Scaffolds Specifically Targeting Five Subtypes of Somatostatin Receptors

P2860

Q34480762-8D13E444-A85F-47A0-95F2-F605516F3FD1 Q35103872-DAD3E849-3A55-44AA-A99E-CD7F094A31DC Q35650466-C79D360C-C960-4574-B829-171D896310F9 Q36876855-ED20A3E2-60A2-4A0F-AA8C-EAFBF8FB01A1 Q37039704-318A98D1-088E-47E8-9C5B-B93278EA94FF Q37426662-6F91AA3B-A80E-4597-A80C-482B8CEB5E7D Q37731335-C27F16FB-C1D9-416E-9022-573E539E0F98 Q39973557-E16CC0D7-985E-4A77-B250-5CB9C80A1F1A Q41830440-1BB7C622-4DBF-40A8-AC75-83D069A4498E Q42666778-17AB5C39-786C-4BD5-AC70-0F46047C0AE8 Q42959578-52D61B4A-7EAE-41E4-B59F-371E6418C73E Q46245973-B4156400-4916-4097-B6EE-0825BE61C505 Q48379498-1ADCCDBD-49D5-4429-BB86-CB3641651192 Q48930641-EC22564A-C768-44CE-A36F-41ACC96B2C93 Q49352143-054BB97B-C6CE-4A09-B764-94B2AB41F239 Q57144951-D4A01F0E-DDDE-4E72-AF60-4E2CE228B9D4 Q57273387-9166E1A7-EEB8-42F5-96A5-057649623EE8

P2860

SST3-selective potent peptidic somatostatin receptor antagonists.

http://www.wikidata.org/entity/Q35582980

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

SST3-selective potent peptidic somatostatin receptor antagonists.

@ast

SST3-selective potent peptidic somatostatin receptor antagonists.

@en

type

label

SST3-selective potent peptidic somatostatin receptor antagonists.

@ast

SST3-selective potent peptidic somatostatin receptor antagonists.

@en

prefLabel

SST3-selective potent peptidic somatostatin receptor antagonists.

@ast

SST3-selective potent peptidic somatostatin receptor antagonists.

@en

P1433

Q35582980-64BF2024-2E28-4CFD-A8C0-F0D9BCED621F

P1476

Q35582980-3C1CE518-EFCD-4D62-AD8E-43D485251794

P2093

Q35582980-1DB2E0C4-33C4-4915-80CF-306C0B316079

Q35582980-241E7BAF-9996-4911-A8D5-829DBD7A7879

Q35582980-369B9CBF-92FF-431E-AF2F-98128F9636C3

Q35582980-435C7B38-313E-416D-8617-F58BE0EE38F6

Q35582980-4611646A-AAED-448C-AE9D-82316E376F9F

Q35582980-530EEFF2-9A00-4288-B401-9D1575A03323

Q35582980-ACE9B959-511E-4551-98B4-3436761CB2BC

P2860

Q35582980-0B3217F9-B9D9-4611-B0B1-1C2D89965FC4

Q35582980-246A00AC-950C-489D-9A1C-6742A8E65E71

Q35582980-2B67D1C3-B2BD-4A8E-9831-3734577269A6

Q35582980-314DD3D4-0C87-4A6E-9FA4-086B8382631E

Q35582980-497D0115-2FF0-4FCC-A8FD-66D01C2C2A0F

Q35582980-52ECA961-75DE-4513-B6B7-B15F5C1B0687

Q35582980-5D859B97-CF88-4B55-BCD0-A9534141C248

Q35582980-60A01207-ADC6-45B9-B790-FFBEFCC5636E

Q35582980-6E5163E1-29B6-4950-8899-BA2417145610

Q35582980-7D9D20F3-D11E-4BBC-9A02-64E1F03FD23A

P304

Q35582980-C91A1364-5F08-4042-9D1B-45EAB9595CCB

P31

Q35582980-C540D11E-DDDB-41E2-AEAC-71AC3ACEE9BB

P356

Q35582980-C3FA4E33-AD68-4858-9535-1ADCC7A32398

P407

Q35582980-F94159B8-6DDC-44AF-8C7E-A73971FBA8F2

P433

Q35582980-4CCAB47D-152E-4D24-9E48-DD1A4B024C60

P478

Q35582980-41245799-4540-4CFB-A4A3-E80304A51182

P577

Q35582980-1ADFFEA9-4204-4C51-AF67-EF0A46EB39AD

P5875

Q35582980-C702088F-0814-4B19-9417-66C95455927A

P698

Q35582980-DF75B5D1-CBBF-4D23-A9D2-B096242F6FD2

P932

Q35582980-4E06AA23-7BD7-413E-9A73-A37C3525740F

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

SST3-selective potent peptidic somatostatin receptor antagonists.

@en

P2093

B Waser

http://www.w3.org/2001/XMLSchema#string

C Hoeger

http://www.w3.org/2001/XMLSchema#string

J C Reubi

http://www.w3.org/2001/XMLSchema#string

J C Schaer

http://www.w3.org/2001/XMLSchema#string

J Erchegyi

http://www.w3.org/2001/XMLSchema#string

J Rivier

http://www.w3.org/2001/XMLSchema#string

S Wenger

http://www.w3.org/2001/XMLSchema#string

P2860

Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Classification and nomenclature of somatostatin receptors

Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin

Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.

(R)-tert-Butoxycarbonylamino-fluorenylmethoxycarbonyl-glycine from (S)-benzyloxycarbonyl-serine or from papain resolution of the corresponding amide or methyl ester.

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

Somatostatin receptor subtype gene expression in pituitary adenomas.

Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphai1 and Galphao.

Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms

P304

13973-13978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.250483897

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24448838

http://www.w3.org/2001/XMLSchema#string

P698

11095748

http://www.w3.org/2001/XMLSchema#string

P932

17685

http://www.w3.org/2001/XMLSchema#string